Fluvoxamine
 
German Version
 

Fluvoxamine (E)-5-Methoxy-4'-(trifluormethyl)valerophenon-O-(2-aminoethyl)oxim, C18H21F3N2O2, M 318,35 g/mol

Selective Serotonin Reuptake Inhibitor (SSRI)

Trade Mark: Luvox®, Fevarin®

 

Application

Treatment of depressions. In the USA, studies run for the treatment of children with fear conditions.

Interactions

Do not use with MAO inhibitors, because of the danger of a Serotonine syndrome. Do not use at the same time with Tizanidin (Sirdalud)

Adverse Effects

Especially at the beginning, nausea, constipation, agitation and weight loss can occur. When setting off, reduce dose slowly, increased risk of suicides.

Analytics

The determination of Fluvoxamine can take place after extraction by means of HPLC/DAD. Therapeutic levels: 0.15-0.25 µg/ml.

Custom Search

 

 

 

Last modification (M-D-Y): 02/08/2019 - IMPRINT - FAQ